Asia Pacific Prenatal & Newborn Genetic Testing Market
Buy Now Request Sample Explore
Home › Report Store › Life Sciences  › Asia Pacific Prenatal & Newborn Genetic Testing Market

Asia Pacific Prenatal & Newborn Genetic Testing Market

The Asia Pacific Prenatal & Newborn Genetic Testing Market size was valued at US$ 630.914 Mn in 2018 and is projected to reach US$ 1,679.956 Mn by 2027, growing at a CAGR of 11.6% during 2019 - 2027.

Report Coverage
  • Product: Diagnostic, Screening
  • Disease Indication: Cystic Fibrosis, Sickle Cell Anemia, Down Syndrome, Phenylketonuria, Recurrent Pregnancy Loss, Antiphospholipid Syndrome, Other Diseases
  • Technology: Spectrophotometer, Polymerase Chain Reaction, Fluorescence In-situ Hybridization, Array Comparative Genomic Hybridization
  • End User: Hospitals & Clinics, Diagnostic Centers, Other End User
US$ 630.914 Mn Market size in 2018
US$ 1,679.956 Mn Market Size by 2027
11.6% CAGR, 2019 - 2027
2019-2027 Forecast Period

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Asia Pacific Prenatal & Newborn Genetic Testing Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Prenatal & Newborn Genetic Testing Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Asia Pacific Prenatal & Newborn Genetic Testing Market Regional Analysis

6.2 Asia Pacific Prenatal & Newborn Genetic Testing Market Revenue 2016-2027 (US$ Million)
6.3 Asia Pacific Prenatal & Newborn Genetic Testing Market Forecast Analysis

7. Asia Pacific Prenatal & Newborn Genetic Testing Market Analysis – by Product

7.1 Diagnostic
  • 7.1.1 Overview
  • 7.1.2 Diagnostic: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)
7.2 Screening
  • 7.2.1 Overview
  • 7.2.2 Screening: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)

8. Asia Pacific Prenatal & Newborn Genetic Testing Market Analysis – by Disease Indication

8.1 Cystic Fibrosis
  • 8.1.1 Overview
  • 8.1.2 Cystic Fibrosis: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)
8.2 Sickle Cell Anemia
  • 8.2.1 Overview
  • 8.2.2 Sickle Cell Anemia: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)
8.3 Down Syndrome
  • 8.3.1 Overview
  • 8.3.2 Down Syndrome: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)
8.4 Phenylketonuria
  • 8.4.1 Overview
  • 8.4.2 Phenylketonuria: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)
8.5 Recurrent Pregnancy Loss
  • 8.5.1 Overview
  • 8.5.2 Recurrent Pregnancy Loss: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)
8.6 Antiphospholipid Syndrome
  • 8.6.1 Overview
  • 8.6.2 Antiphospholipid Syndrome: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)
8.7 Other Diseases
  • 8.7.1 Overview
  • 8.7.2 Other Diseases: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)

9. Asia Pacific Prenatal & Newborn Genetic Testing Market Analysis – by Technology

9.1 Spectrophotometer
  • 9.1.1 Overview
  • 9.1.2 Spectrophotometer: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)
9.2 Polymerase Chain Reaction
  • 9.2.1 Overview
  • 9.2.2 Polymerase Chain Reaction: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)
9.3 Fluorescence In-situ Hybridization
  • 9.3.1 Overview
  • 9.3.2 Fluorescence In-situ Hybridization: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)
9.4 Array Comparative Genomic Hybridization
  • 9.4.1 Overview
  • 9.4.2 Array Comparative Genomic Hybridization: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)

10. Asia Pacific Prenatal & Newborn Genetic Testing Market Analysis – by End User

10.1 Hospitals & Clinics
  • 10.1.1 Overview
  • 10.1.2 Hospitals & Clinics: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)
10.2 Diagnostic Centers
  • 10.2.1 Overview
  • 10.2.2 Diagnostic Centers: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)
10.3 Other End User
  • 10.3.1 Overview
  • 10.3.2 Other End User: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast, 2016-2027 (US$ Million)

11. Asia Pacific Prenatal & Newborn Genetic Testing Market – Asia-Pacific Analysis

11.1 Overview

11.2 Asia-Pacific
  • 11.2.1 Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Key Country, 2019 and 2027 (%)
  • 11.2.1.1 Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast Analysis – by Country
  • 11.2.1.1 China: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)
    • 11.2.1.1.1 China: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Product
    • 11.2.1.1.2 China: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Disease Indication
    • 11.2.1.1.3 China: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Technology
    • 11.2.1.1.4 China: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by End User
  • 11.2.1.2 India: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)
    • 11.2.1.2.1 India: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Product
    • 11.2.1.2.2 India: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Disease Indication
    • 11.2.1.2.3 India: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Technology
    • 11.2.1.2.4 India: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by End User
  • 11.2.1.3 Japan: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)
    • 11.2.1.3.1 Japan: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Product
    • 11.2.1.3.2 Japan: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Disease Indication
    • 11.2.1.3.3 Japan: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Technology
    • 11.2.1.3.4 Japan: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by End User
  • 11.2.1.4 Australia: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)
    • 11.2.1.4.1 Australia: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Product
    • 11.2.1.4.2 Australia: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Disease Indication
    • 11.2.1.4.3 Australia: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Technology
    • 11.2.1.4.4 Australia: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by End User
  • 11.2.1.5 Rest of Asia-Pacific : Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)
    • 11.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Product
    • 11.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Disease Indication
    • 11.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Technology
    • 11.2.1.5.4 Rest of Asia-Pacific : Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis
12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments

14. Company Profiles

14.1 LifeCell
  • 14.1.1 Key Facts
  • 14.1.2 Business Description
  • 14.1.3 Products and Services
  • 14.1.4 Financial Overview
  • 14.1.5 SWOT Analysis
  • 14.1.6 Key Developments
14.2 Quest Diagnostics Incorporated
  • 14.2.1 Key Facts
  • 14.2.2 Business Description
  • 14.2.3 Products and Services
  • 14.2.4 Financial Overview
  • 14.2.5 SWOT Analysis
  • 14.2.6 Key Developments
14.3 Medgenome
  • 14.3.1 Key Facts
  • 14.3.2 Business Description
  • 14.3.3 Products and Services
  • 14.3.4 Financial Overview
  • 14.3.5 SWOT Analysis
  • 14.3.6 Key Developments
14.4 Eurofins Scientific
  • 14.4.1 Key Facts
  • 14.4.2 Business Description
  • 14.4.3 Products and Services
  • 14.4.4 Financial Overview
  • 14.4.5 SWOT Analysis
  • 14.4.6 Key Developments
14.5 Metropolis India
  • 14.5.1 Key Facts
  • 14.5.2 Business Description
  • 14.5.3 Products and Services
  • 14.5.4 Financial Overview
  • 14.5.5 SWOT Analysis
  • 14.5.6 Key Developments
14.6 SRL Diagnostics
  • 14.6.1 Key Facts
  • 14.6.2 Business Description
  • 14.6.3 Products and Services
  • 14.6.4 Financial Overview
  • 14.6.5 SWOT Analysis
  • 14.6.6 Key Developments
14.7 Sandor Lifesciences Pvt Ltd
  • 14.7.1 Key Facts
  • 14.7.2 Business Description
  • 14.7.3 Products and Services
  • 14.7.4 Financial Overview
  • 14.7.5 SWOT Analysis
  • 14.7.6 Key Developments
14.8 PerkinElmer, Inc.
  • 14.8.1 Key Facts
  • 14.8.2 Business Description
  • 14.8.3 Products and Services
  • 14.8.4 Financial Overview
  • 14.8.5 SWOT Analysis
  • 14.8.6 Key Developments
14.9 Natera, Inc.
  • 14.9.1 Key Facts
  • 14.9.2 Business Description
  • 14.9.3 Products and Services
  • 14.9.4 Financial Overview
  • 14.9.5 SWOT Analysis
  • 14.9.6 Key Developments
14.10 Laboratory Corporation of America Holdings (Sequenom)
  • 14.10.1 Key Facts
  • 14.10.2 Business Description
  • 14.10.3 Products and Services
  • 14.10.4 Financial Overview
  • 14.10.5 SWOT Analysis
  • 14.10.6 Key Developments
14.11 Genes2Me LLP
  • 14.11.1 Key Facts
  • 14.11.2 Business Description
  • 14.11.3 Products and Services
  • 14.11.4 Financial Overview
  • 14.11.5 SWOT Analysis
  • 14.11.6 Key Developments
14.12 Illumina, Inc.
  • 14.12.1 Key Facts
  • 14.12.2 Business Description
  • 14.12.3 Products and Services
  • 14.12.4 Financial Overview
  • 14.12.5 SWOT Analysis
  • 14.12.6 Key Developments

15. Appendix

15.1 About Business Market Insights
15.2 List of Abbreviations

Access the Full A Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Download Sample Request Customization
Access the full A Market Report
281 pages PDF & Excel | 2019-09-04
Download Sample Customization